Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Decode Slide 9.8 Percent on News of Poor Q4 Earnings, Revenue Growth

NEW YORK, March 4 (GenomeWeb News) - Shares in Decode Genetics were down 9.76 percent, or $.61, at $5.64 in mid-afternoon trading after the company posted a slight decrease in fourth-quarter revenues atop nearly doubled net losses.


As GenomeWeb News reported this morning, total revenues for the three-month period ended Dec. 31, 2004, fell to $11.2 million from $11.7 million during the same period a year ago.


R&D expenses increased to $8.7 million from $5.8 million during the fourth quarter of 2003. This increase was mainly due to costs associated with clinical trials for two compounds, according to Decode.


Decode's net loss for the quarter swelled to $19.4 million, or $.36 per share, from $10.6 million, or $.20 per share, during the same period in 2003. This steep increase resulted from costs of clinical trials, debt service, and the impact of foreign exchange fluctuations, according to the company.


As of Dec. 31, 2004, Decode had $198.3 million in cash and investments, including restricted cash, cash equivalents, marketable securities, and other investments.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.